The mechanism by which docking fidelity is achieved for the multitude of cofactor-dependent enzymes is poorly understood. In this study, we demonstrate that delivery of coenzyme B12 or 5-deoxyadenosylcobalamin by adenosyltransferase to methylmalonyl-CoA mutase is gated by a small G protein, MeaB. While the GTP-binding energy is needed for the editing function; that is, to discriminate between active and inactive cofactor forms, the chemical energy of GTP hydrolysis is required for gating cofactor transfer. The G protein chaperone also exerts its editing function during turnover by using the binding energy of GTP to elicit release of inactive cofactor that is occasionally formed during the catalytic cycle of MCM. The physiological relevance of this mechanism is demonstrated by a patient mutation in methylmalonyl-CoA mutase that does not impair the activity of this enzyme per se but corrupts both the fidelity of the cofactor-loading process and the ejection of inactive cofactor that forms occasionally during catalysis. Consequently, cofactor in the incorrect oxidation state gains access to the mutase active site and is not released if generated during catalysis, leading, respectively, to assembly and accumulation of inactive enzyme and resulting in methylmalonic aciduria.
C ellular strategies for achieving fidelity during cofactor assembly are needed to avert reconstitution of inactive enzymes. With metalloproteins, intricate mechanisms are deployed for receiving, elaborating [in the case of metal clusters (1)] and delivering metal cofactors to target enzymes (2) . Derivatives of vitamin B 12 or cobalamin, are organometallic cofactors that are used by only two mammalian enzymes (3, 4) : the mitochondrial methylmalonyl-CoA mutase (MCM) (5) and the cytoplasmic methionine synthase (6) . In circulation, cobalamin is associated with a high-affinity binder, transcobalamin II (TCII) (7) , which is delivered to cells via a specific cell surface TCII receptor (8) . Following endocytosis into the acidic compartment of the lysosome, cobalamin is released, TCII is proteolyzed and the receptor is recycled. It has been postulated (9, 10) that from its point of egress into the cytoplasm, which is dependent on a lysosomal membrane protein, LMBD1 (11) , cobalamin is protein-bound and escorted to the two B 12 -dependent enzymes found in mammals. The strategy for escorted delivery of cobalamin to its target enzymes would minimize adventitious reactions of a rare and reactive cofactor while also ensuring specificity in a crowded intracellular milieu. The cobalamin-trafficking pathway tailors the inactive cofactor forms arriving in the cell into its biologically active forms, methylcobalamin and 5Ј-deoxyadenosylcobalamin (AdoCbl) needed by methionine synthase and MCM, respectively, with the conversion of cob(II)alamin to methylcobalamin occurring presumably on methionine synthase (10) .
Following its arrival into the mitochondrion, the inactive cob(II)alamin form of the cofactor is converted via the action of adenosyltransferase (ATR) to the active AdoCbl form (12, 13) . ATR serves not only to tailor the active cofactor, but also to deliver it to the target enzyme, MCM (14) . ATR from Methylobacterium extorquens AM1 is a trimeric enzyme that binds up to two molecules of AdoCbl in an atypical ''base-off'' fivecoordinate state (14, 15) in contrast to MCM, in which a histidine residue on the protein coordinates AdoCbl to give a base-off/ His-on six-coordinate state (Fig. 1) . This difference in coordination number results in a large spectroscopic difference that is useful for locating the cofactor. It is also exploited for direct cofactor translocation during which the histidine ligand in MCM plays a role in moving the cofactor from ATR to MCM (14) . The usage of only two of the three active sites in ATR is functionally important for driving transfer of AdoCbl to MCM. Thus, ATR operates via a rotary mechanism in which binding of ATP to the vacant site in ATR leads to ejection of one equivalent of AdoCbl from an adjacent active site (16) . However, AdoCbl moves reversibly between the active sites in this two-protein ATR:MCM system with the equilibrium favoring the ATR site (14) , and insights into screening mechanisms that preclude transfer of the inactive cob(II)alamin form have been lacking.
Isolated methylmalonic aciduria is a rare genetic disorder and most commonly results from mutations in one of three loci: cblA, cblB, and mut, encoding the mitochondrially localized proteins, MMAA (for methylmalonic aciduria type A), ATR and MCM, respectively (17) . A G protein chaperone from M. extorquens AM1, MeaB, which is orthologous to the human MMAA protein, binds MCM with nanomolar affinity (18) , suggesting that the two proteins are likely to exist in a complex intracellularly. MeaB exhibits low intrinsic GTPase activity, which is enhanced approximately 100-fold in the MCM:MeaB complex. Similarly, the presence of MeaB modulates MCM function, protecting this radical enzyme from oxidative inactivation and enhancing its turnover number approximately 2-fold (19) .
In this study, we demonstrate that MeaB, a bacterial ortholog of a mitochondrial protein involved in AdoCbl trafficking (20) , functions as an editor, discriminating between inactive and active cofactor forms and permitting transfer only of AdoCbl, in a process that is gated by GTP hydrolysis. The editing function of MeaB is also used for rescuing inactivated mutase formed occasionally during turnover. A patient mutation in MCM results in methylmalonic aciduria by corrupting the fidelity of the cofactor loading process.
Results and Discussion

GTP-Dependent Gating by MeaB of AdoCbl Transfer from ATR to MCM.
We have previously shown that AdoCbl is transferred reversibly between the active sites of ATR and MCM when the holo-form of one protein is rapidly mixed with the apo-form of the other (14) . Remarkably, when AdoCbl-loaded ATR (holo-ATR) is mixed with a stoichiometric complex of MCM:MeaB⅐GTP, no cofactor transfer is observed ( Fig. 2A) . This is in striking contrast to the ATP-independent transfer of cofactor observed previously in the absence of MeaB⅐GTP (14) . Indeed, in the absence of ATP, transfer of AdoCbl from ATR to MCM is inhibited at increasing concentrations of MeaB until a stoichiometric complex of MCM:MeaB⅐nucleotide is formed (Fig. 2B) . Addition of ATP drives the transfer of a single equivalent of AdoCbl from ATR to MCM and is paralleled by a corresponding increase in MCM activity under these conditions (Fig. 2 A) . Significantly, when the same experiment is conducted in the presence of GMPPNP, a non-hydrolysable analog of GTP, MCM activity is undetectable and ATP triggers the release of AdoCbl from holo-ATR into solution. The productive transfer of AdoCbl from ATR is confirmed by enzyme-monitored turnover of MCM in which approximately 30% of the cofactor exists as cob(II)alamin under steady-state conditions when GTP but not GMPPNP is used in the cofactor transfer experiment (Fig. 2C and Fig. S1 ). These results demonstrate that MeaB utilizes the energy of GTP hydrolysis to gate AdoCbl transfer from holo-ATR to MCM. GTP hydrolysis is also used by UreG, for nickel delivery to urease (21) and by HypB during maturation of the NiFe hydrogenase (22) . MeaB, UreG, and HypB all belong to the G3E subfamily of P-loop GTPases (23).
Nucleotide-Dependent Editing of Cofactor Transfer from ATR to MCM.
Maturation of MCM appears to be governed by two nucleotide switches: ATP binding to ATR and GTP hydrolysis by MeaB. Next, we examined if either nucleotide switch is involved in preventing transfer of the inactive cob(II)alamin form of the cofactor from ATR to MCM. The M. extorquens ATR binds cob(II)alamin in a mixture of the base-on and base-off states (Fig. S2 a) . The base-off state found in ATR is further distinguished into five-or four-coordinate species in which the lower axial position is occupied by a weak ligand such as water (-ATP) or is vacant (ϩATP), and yields EPR spectra that are similar to those observed previously for human ATR (15, 24) . In contrast, MCM binds cob(II)alamin in a base-off/His-on five-coordinate state in which the lower axial ligand is the imidazole side chain of a histidine residue (25) . A distinguishing feature of the EPR spectra of cob(II)alamin with or without a nitrogenous axial ligand is the appearance of triplet versus singlet structures respectively in the octet of hyperfine lines that result from the interactions between the unpaired electron and the cobalt nucleus (I ϭ 7/2) (Fig. S2) . When increasing concentrations of MCM are incubated with ATR⅐cob(II)alamin, conversion of the base-off to the base-off/His-on state is observed, consistent with the transfer of the cofactor from ATR to MCM (Fig. S2b) . The transfer of cob(II)alamin is unaffected by ATP as evidenced by the conversion of the four-coordinate base-off spectrum associated with ATR to a five-coordinate base-off/His-on spectrum associated with MCM (Fig. S2c) . Under these conditions, cofactor transfer is apparently unidirectional, as transfer from holo-MCM to ATR was not detected Ϯ ATP (Fig. S2d) . ATP does not induce release of cob(II)alamin from ATR in the absence or presence of MCM:MeaB⅐GTP (Fig. S3) . Importantly, while MeaB or MeaB⅐GDP do not protect MCM from being loaded with cob(II)alamin from ATR, MeaB⅐GT P or MeaB⅐GMPPNP impede the process (Fig. 3A) . Since GTP and GMPPNP have similar effects, GTP binding rather than hydrolysis is used for cofactor editing by MeaB to shield MCM from irreversible inactivation. Ϫ3 min Ϫ1 at 20°C leading to formation of the inactive aquocobalamin (H 2 OCbl) species (19) . H 2 OCbl remains tightly bound to MCM and only a small fraction is released in the absence (3.0 Ϯ 0.6%) or presence of MeaB (5.4 Ϯ 0.4%) or MeaB⅐GTP (11.0 Ϯ 1.8%) (Fig. S4) . In the absence of a mechanism for releasing inactive cofactor, this would eventually lead to accumulation of completely inactive MCM.
Since MeaB in the presence of nucleotides is ineffective at releasing H 2 OCbl from MCM, we assessed whether it can induce release of cob(II)alamin that has become uncoupled from the organic radical intermediates that form during turnover. While the EPR spectrum of MCM reconstituted with cob(II)alamin is not perturbed by the presence of MeaB or MeaB⅐GDP (Fig. 4A , spectra i and ii), the addition of MeaB⅐GTP or MeaB⅐GMPPNP elicit subtle spectral changes in the S-shaped absorption feature at g Ϸ2.28 (Fig. 4A , spectra iii and iv). Thus, the hyperfine structure associated with this feature when the cofactor is bound to the active site is lost, as observed for cob(II)alamin in solution (Fig. 4 A, spectrum v) . To confirm this obser vation, MCM⅐cob(II)alamin was mixed with MeaBϮnucleotides and the free cofactor was separated using a Centricon concentrator. Analysis of the filtrate by absorption spectroscopy confirmed that cob(II)alamin remains associated with MCM in the presence of MeaBϮGDP, which is in striking contrast to the situation with MeaB and either GTP or GMPPNP (Fig. 4B) . Since GTP and GMPPNP elicit similar effects, it suggests that the energy of GTP binding rather than hydrolysis is used for cofactor editing following inactivation during catalytic turnover.
The ability of MeaB⅐GTP to catalyze expulsion of cob(I-I)alamin from MCM begs the question as to how this activity is suppressed during turnover conditions when cob(II)alamin is a constituent of the biradical intermediate and the other radical is either cofactor-[i.e., 5Ј-deoxyadenosyl-], substrate-, or productderived. Other B 12 enzymes have mechanisms either for the in situ repair of oxidized cofactor as in methionine synthase (26, 27) or for the exchange of inactive cofactor for AdoCbl that is mediated via an ATP-dependent chaperone as in diol dehydratase (28, 29) . We have previously shown that the presence of MeaB⅐GDP or MeaB⅐GTP confers protection against oxidative interception of cob(II)alamin decelerating the rate of OH 2 Cbl formation by 4-and 19-fold, respectively (19) . Under catalytic turnover conditions when MCM reconstituted with AdoCbl is mixed with methylmalonyl-CoA in the absence or presence of MeaB Ϯnucleotides, we could not detect release of any cofactor over an approximate 40-min time period. This is consistent with the very slow rate of inactivation of MCM under turnover conditions. Similarly, when MCM was reconstituted with cob(I-I)alamin and 5Ј-deoxyadenosine (as a mimic of the 5Ј-deoxyadenosyl radical), in the presence or absence of the substrate, methylmalonyl-CoA, it was resistant to MeaB⅐GTP-induced release of cob(II)alamin (Fig. 4C) . These results imply that MeaB safeguards the radical intermediates during turnover conditions and that the occasional loss of the deoxyadenosine moiety rather than oxidation of cob(II)alamin signals formation of inactive MCM, triggering release of the cofactor by MeaB⅐GTP. Interestingly, substitution of 5Ј-deoxyadenosine by adenosine in these experiments leads to a GTP hydrolysis dependence of cob(II)alamin release from MCM (Fig. 4C) , indicating transmission of information about ligand-specific interactions between the 5Ј-deoxyadenosine binding site in MCM and MeaB. 
A Patient Mutation in MCM Corrupts the Editing Function of MeaB.
The physiological relevance of the cofactor-gating/editing model is demonstrated by the R585C mutation in the M. extorquens MCM, which was designed to mimic the pathogenic mutation, R616C, identified in a patient with methylmalonic aciduria (30) . Homozygosity of this mutation results in an approximately 86% reduction in intracellular AdoCbl levels (30) . The arginine residue resides at a solvent exposed edge of the B 12 binding domain and is distant from the cofactor binding and active sites (Fig. 5A) and is involved in a network of hydrogen bonding interactions with neighboring residues (Fig. S5) . When the kinetic properties of the mutant were evaluated in assays in which MCM is reconstituted with exogenous AdoCbl, no obvious deficits were seen (Table 1) . Similarly, in assays in which AdoCbl was transferred from holo-ATR to the mutant, the cofactor transfer efficiency was comparable to that of wild-type MCM (Fig. S6) . However, a profound phenotype was evident when the interaction of R585C and its GTPase activating protein (GAP) activity were interrogated in the presence of MeaB. The mutation decreases the affinity of MCM for MeaB⅐GDP and MeaB⅐GTP by approximately 80-and 9-fold respectively and reduces the k cat /K m for GAP activity 280-fold (Table 1 and Fig.  5B ). The diminished affinity of R585C MCM for MeaB⅐nucleotide is accompanied by a large reduction in the enthalpy of binding compared to wild-type MCM (⌬⌬H ϭ 20.8-22.5 kcal/mol) (Fig. S7) and suggests a role for the arginine residue in stabilizing the MCM:MeaB complex. GAPs often furnish an arginine ''finger'' that stabilizes the transition state in the G protein active site (31) . We speculate that the R585 residue might play this role in enhancing the GTPase activity of MeaB or could modulate it indirectly.
The functional deficiencies in the R585C mutant were further evident when holo-ATR was used as the cofactor source in the presence of MeaB (Fig. 2B) . In marked contrast to wild-type MCM, the presence of MeaB stimulated the ATP-independent transfer of AdoCbl from holo-ATR to R585C MCM. Furthermore, the mutation compromises the GTP-dependent editing function of MeaB, resulting in its failure to safeguard the mutant MCM from reconstitution with cob(II)alamin in the presence of GTP or GMPPNP (Fig. 3B) . The R585C mutation also impairs release of inactive cofactor from MCM⅐cob(II)alamin in the presence or absence of nucleotides (Fig. 4B) . This loss of function cannot simply be ascribed to the reduced binding affinity between R585C MCM and MeaB, since the experiments were performed under conditions where Ͼ96% of the mutant was present in complex with MeaB. Rather, the mutation appears to impair the ability of the MCM:MeaB complex to adopt and/or stabilize the editing conformation induced by GTP binding. This loss of editing function can explain the biochemical phenotype of the patient cell line (30) since capture of cob(I-I)alamin by the mutant would lead to inactive MCM, with consequent reduction in propionate incorporation, and diminished AdoCbl levels as observed in patient fibroblasts (30) due to depletion of the precursor cob(II)alamin.
A Model for MeaB-Dependent Cofactor Editing and Gating. Based on the results from this study, we propose a model for AdoCbl delivery to MCM (Fig. 5C) . Cob(II)alamin delivered to the mitochondrion is received by ATR by a transport mechanism that awaits elucidation. The nearly equivalent affinity of MeaB for GTP versus GDP (18) implies that the active site of this protein is predominantly loaded with GTP, which is much more abundant in the cell. The conformation of the idle MCM:MMAA⅐GTP complex prevents hijacking of the entering cob(II)alamin, which is instead converted by ATR to AdoCbl. The latter is directly transferred from ATR to the MCM:MMAA⅐GTP complex in a process that is gated by two nucleotide-dependent switches: ATP binding to ATR and GTP hydrolysis. During turnover of MCM, occasional loss of the deoxyadenosine moiety leads to enzyme inactivation as AdoCbl cannot be regenerated at the end of the catalytic cycle. This in turn, elicits a postloading editing function of MMAA in which the GTP binding energy is used to trigger release of inactive cob(II)alamin from the active site of MCM. Pathogenic mutations can potentially interfere with any one of the finely orchestrated steps that govern the fidelity of MCM maturation and lead to disease. Based on our studies on the R585C mutation in the M. extorquens MCM, we predict that the R616C mutation in human MCM has pleiotropic consequences on the integrity of the gating/editing functions of the MCM:MMAA complex and leads to cob(II)alamin capture by and inactivity of MCM and to reduced levels of AdoCbl. The responsiveness of the WG3118 patient cell line harboring the R616C-carrying allele to OHCbl supplementation as assessed by the propionate incorporation assay (30), might be explained by the increased availability of cob(II)alamin for AdoCbl synthesis by ATR versus cob(I-I)alamin hijacking by the MCM:MMAA complex. Interestingly, all patients with mutations in MMAA exhibit in addition to reduced MCM activity, diminished intracellular AdoCbl levels (32), consistent with competition for the limiting mitochondrial cob(II)alamin supply by MCM. Genetic disruption of the meaB gene in M. extorquens leads to complete loss of MCM activity consistent with the presence of the inactive cob(II)alaminloaded enzyme (20) . However, this organism can biosynthesize B 12 (33) and AdoCbl levels are unaffected in the ⌬meaB strain, presumably because cob(II)alamin is not limiting.
In summary, our studies reveal an unprecedented role for a G protein trafficking chaperone that uses the binding energy derived from GTP for editing and the chemical energy released from GTP hydrolysis for gating transfer of AdoCbl from its site of synthesis to its site of utilization. These studies furnish a mechanistic framework for understanding how pathogenic mutations in the mitochondrial trafficking pathway might corrupt this process leading to methylmalonic aciduria.
Materials and Methods
Materials. AdoCbl, OHCbl, nucleotides and other reagent grade chemicals were purchased from Sigma. [ 14 C]-methylmalonyl-CoA (56 Ci/mol) was purchased from New England Nuclear and methylmalonyl-CoA was synthesized as described (34) .
Construction of the R585C Mutant. Plasmids expressing the M. extorquens AM1 MCM, MeaB, and ATR were generous gifts from Mary Lidstrom (University of Washington, Seattle). The R585C mutant of MCM was created using the QuikChange kit (Stratagene) and the following sense primer: 5Ј-CAAGAT-GGGCCAGGACGGGAACGACCGCGGCCAGAAGGTG-3Ј. The antisense mutagenic primer had the complementary sequence. Following PCR amplification, the mutation was confirmed by nucleotide sequence determination at the Genomics Core Facility (University of Nebraska-Lincoln).
Enzyme Assays. The wild-type and R585C MCM, MeaB and ATR were purified as described (14, 18) . The specific activity of MCM was determined in the radiolabeled assay as described (19) . The GTPase activity of MeaB was determined by HPLC as described (18) . Each experiment was performed at least in duplicate. Kinetic parameters for wild-type and R585C MCM. The kinetic parameters for R585C MCM were determined at 37°C in the radiolabeled assay (19) . KM and Vmax were determined in the presence of 100 M AdoCbl and varying concentrations of (R,S)-[ 14 C]-methylmalonyl-CoA (80 -4,000 M). The Kact for AdoCbl was obtained by varying the concentration of the cofactor (1-50 M) and a saturating concentration of the substrate {4 mM (R,S)-[ 14 C]-methylmalonyl-CoA}. MCM activity after cofactor transfer in the presence of MeaB and nucleotides. To avoid cofactor dilution and release in solution during the experiments, the concentration of enzymes in the assay was increased approximately 1,000-fold. As a consequence, after the AdoCbl transfer experiments, the activity measurements were performed on ice to be under initial velocity conditions in the radiolabeled MCM assay. AdoCbl transfer was accomplished at 20°C for 5 min by adding various concentrations of ATP (0 -10 mM) to a reaction mixture containing 8 M holo-ATR (16 M bound AdoCbl) preincubated with MCM (100 M) in complex with MeaB (110 M) and 2 mM GTP or 2 mM GMPPNP in Buffer A (50 mM HEPES buffer, pH 8.0, containing 0.3 M KCl, 15 mM MgCl2, and 5% glycerol). Then, the solutions were incubated for 20 min on ice before starting the assay by addition of 6 mM ice-cold (R,S)-[ 14 C]-methylmalonyl-CoA. After 1 min incubation, the reaction mixtures were quenched and the samples treated as described (14) . Control experiments lacking the complex (negative control) or MeaB (positive control) were performed in parallel. A specific activity of 0.053 Ϯ 0.007 mol min Ϫ1 mg Ϫ1 on ice was measured in the absence of MeaB and denotes 100% activity. Cofactor Transfer Assays. Cofactor transfer between ATR and R585C MCM. The transfer of AdoCbl between the two enzyme active sites was monitored in Buffer A in the presence of 0 -8.3 mM ATP by absorption spectroscopy at 20°C as described (16) . Requirement of GTP hydrolysis for cofactor transfer between Holo-ATR and MCM:MeaB⅐GTP. Holo-ATR (9.5-10 M) was preincubated for 5 min with 51.6 -184 M MCM:MeaB⅐GTP/GMPPNP (2.5 mM nucleotide) in Buffer A at 20°C. Cofactor transfer/release was initiated by addition of 6 mM ATP and the amount of cofactor transferred to MCM or released into solution was estimated using a ⌬525 nm ϭ 7.75 mM Ϫ1 cm Ϫ1 (transfer) or a ⌬ 525 nm ϭ 6.69 mM Ϫ1 cm Ϫ1 (release), respectively. After 10 min incubation, 7.2 mM (R,S)-methylmalonyl-CoA was added to the reaction mixture and the amount of cob(II)alamin generated under steady-state conditions was estimated using a ⌬525 nm ϭ -4.8 mM Ϫ1 cm Ϫ1 . Analysis of the filtrate as described (16) Cofactor Release Assays. MeaB-dependent release of cob(II)alamin from MCM. Wild-type or R585C MCM (60 -70 M) was incubated for 10 min with 45-50 M cob(II)alamin in Buffer A under strictly anaerobic conditions. Then, a 1.5 (MCM) or 2.5 (R585C MCM) molar excess of apo-MeaB, MeaB⅐GDP, MeaB⅐GTP, or MeaB⅐GMPPNP (2-5 mM nucleotides) in Buffer A was added to the MCM solution, incubated for 15 min and frozen for EPR spectroscopy. Following accumulation of the EPR spectra, the samples were thawed, and subjected to air oxidation for 7 h at room temperature. During this time, the MCM:MeaB complex is stable. The reaction mixtures were then filtered through a Centricon YM30 concentrator (5,000 rpm, 45 min, 4°C) and the filtrate was analyzed by UV-visible spectroscopy to estimate the amount of cofactor released from the mutase, 356 nm ϭ 20.6 mM Ϫ1 cm Ϫ1 for OH2Cbl.
To assess the effect of occupancy at the deoxyadenosine binding site on the release of cob(II)alamin from MCM, the same experiments were repeated with MCM (50 -60 M) preincubated for 15 min with 7.5-10 mM 5Ј-deoxyadenosine or adenosine Ϯ 6-9 mM (R)-methylmalonyl-CoA before addition of 45-50 M cob(II)alamin. Then, a 1.5 molar excess of MeaB, MeaB⅐GDP, MeaB⅐GTP, or MeaB⅐GMPPNP in Buffer A was added to the mutase sample and processed as described above. Each experiment was performed at least in duplicate. Analysis of AdoCbl release from MCM under catalytic turnover conditions in the presence of MeaB ؎ nucleotide. MCM (14 -55 M cofactor bound, 525 nm ϭ 9.06 mM Ϫ1 cm Ϫ1 ) was incubated at 20°C for 15 min in Buffer A with a 1.5 molar excess of apo-MeaB, MeaB⅐GDP, MeaB⅐GTP, or MeaB⅐GMPPNP Ϯ 5-9 mM (R)-methylmalonyl-CoA. The order of addition of methylmalonyl-CoA and MeaB did not affect the results. The amount of cofactor released from MCM was quantified using a centricon YM30 filter and analyzing the filtrate by absorption spectroscopy using 525 nm ϭ 8 mM Ϫ1 cm Ϫ1 . The experiments were performed at least in quadruplicate.
Isothermal Titration Calorimetry (ITC).
ITC experiments were performed to study (i) binding of AdoCbl to wild-type or R585C MCM and (ii) the interaction between R585C MCM with MeaB Ϯ nucleotides as described (18, 19) . Each experiment was performed at least in triplicate in Buffer A at 20°C. EPR Spectroscopy. EPR spectra were recorded on a Bruker EMX spectrometer (Bruker Biospin Corp.), equipped with an Oxford ITC4 temperature controller, a Hewlett-Packard model 5340 automatic frequency counter, and Bruker gaussmeter. Unless otherwise noted, the EPR spectroscopic parameters included the following: temperature, 100 K; microwave power, 25 mW; microwave frequency, 9.38 GHz; receiver gain, 2 ϫ 10 5 ; modulation amplitude, 10 G; modulation frequency, 100 kHz.
